4^th Macrophage-directed Therapies Summit, taking place from 4-6 of October in Boston, will bring together professionals to accelerate the clinical validation of macrophage-directed therapies, manipulating and fixing phenotypic plasticity to develop safe, targeted therapies for oncology, autoimmunity, inflammation and beyond.

Join your peers in person and delve into:

• CD47 targeting and other ‘don’t eat me’ signals
• Safety concerns due to model translatability and dosing
• Optimal combination or monotherapy discovery

You can view the event guide here: https://ter.li/ezyi0h

Secure your place at the summit here: https://ter.li/x9p0ua

We are looking forward to welcoming you to Boston this October!